The Purpose of This Research Study is to Compare the Efficacy and Safety of SCT630 and Adalimumab (HUMIRA®) in Adults With Plaque Psoriasis
Clinical trial NCT03927352 · UNKNOWN
Trial details
- NCT number
- NCT03927352
- Sponsor
- Sinocelltech Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-05
- Primary completion
- 2021-12-31
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.